Biotechnology in Taiwan is booming, with the number of companies growing by 188.6% to 83 and capitalization increasing by 360.0% to $21.13 billion from 2009 to 2103. Over the last 15 years, the government has contributed $100–$200 million annually to biotech, facilitating the shift from clinical trials of foreign-developed drugs to drug discovery within Taiwan. […]
To address climate change, the EPA has proposed guidelines for states in developing plans to reduce greenhouse gas (GHG) emissions from fossil-fueled electric-generating units (EGUs). The guidelines are based on state-specific rate-based goals for carbon dioxide emissions from power plants. Carbon dioxide accounts for 82% of US GHG emissions. The rule is designed to reduce […]
Use of renewable energy continued to grow in 2013. In 2013, biomass represented around 10% of global primary energy supply. In the power-generation market, bio-power added 5 GW of capacity last year, bringing the total to 88 GW, and solar-photovoltaic capacity increased by 39 GW to 139 GW. Capacity also increased for the other categories […]
Genetic testing is becoming standard at cancer hospitals in order to advance drug trials and treatment. In the latest example, Quest Diagnostics and Sloan Kettering are partnering to screen patients, aiming to test for 341 genes in 2015. Although the test will cost $4,000, patients will not pay the full amount. Sloan Kettering intends to […]
First quarter Life Science Index sales grew 5.0%, 7.1% on a currency-neutral basis, to $3,387 million. Index sales were driven by double-digit organic revenue growth each for Illumina, Fluidigm, BD Biosciences and Biotage. Operating profit climbed 11.0% to $719 million. Based on current operations, operating margin expanded 90 basis points to 19.4% of sales. Of […]
Newtown, PA 6/6/14—GGA Software Services, a supplier of scientific-informatics services, has been acquired by EPAM Systems, a publicly held provider of product-development and software-engineering solutions, for cash and $10 million in stock. “Not only are we very excited about the significant growth opportunity in the Life Sciences and Healthcare industry verticals, we also see tremendous […]
Bonn, Germany 5/22/14—German firm KonTEM, a developer of phase-contrast technology for TEM, has been acquired by FEI for an undisclosed amount. High-Tech Gründerfonds, an investor in KonTEM, announced the sale. KonTEM’s technology improves image contrast without affecting resolution. KonTEM is a spin-off of the Max Planck Society and the Center for Advanced European Studies and […]
Radnor, PA 6/4/14—VWR has acquired LABRepCo, a distributor of lab equipment to the eastern US. Financial details were not disclosed. LABRepCo specializes in lab equipment supply and partnering in new lab builds and renovations through consultative relationships. “Like VWR, LABRepCo believes that its people are what differentiate them in the industry,” said Mark McLoughlin, senior […]
Malvern, UK 6/4/14; Engham, UK 6/4/14—Malvern Instruments, a Spectris business and provider of materials and biophysical-characterization technology, has acquired MicroCal from GE Healthcare Life Sciences for an undisclosed amount. A provider of differential scanning calorimeters and isothermal-titration calorimeters, MicroCal generates $30 million in annual revenues. “MicroCal products are an excellent fit with Malvern’s existing portfolio […]
Basel, Germany 6/2/14—Roche has acquired Genia Technologies, a developer of single-molecule DNA-sequencing technology, for $125 million in cash and up to $225 million in contingent payments. Genia’s platform employs semiconductor-based nanopore technology and is expected to reduce the price of sequencing. The platform allows for electrical real-time analysis without the need for complicated optics, labels, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
